Answers are grounded in this paper and cite their sources.
An international initiative reveals effective screening for primary ciliary dyskinesia in resource-limited settings, suggesting genetic testing could improve early intervention.
In resource-limited settings, diagnosis of PCD is often delayed. A combined screening strategy using HSVA and nasal NO testing can help identify likely PCD cases and facilitate early intervention. HSVA and nNO testing were found to be complementary in the screening of PCD. Genetic testing was used in a subset of patients to confirm diagnosis and was conclusive in 54% of tested.
No takes yet. Share an insight, caveat, or question.
Benjamin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: